Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC7H15ClN2O3S |
InChIKeyLYLDPAYWSCPRTI-JEDNCBNOSA-N |
CAS Registry51785-99-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | - | - |